Concord Biotech Limited – NSE:CONCORDBIO.NS

Concord Biotech Limited stock price today

INR 1,658.9
-506.29
-23.38%
Financial Health
0
1
2
3
4
5
6
7
8
9

Concord Biotech Limited stock price monthly change

+28.13%
month

Concord Biotech Limited stock price quarterly change

+28.13%
quarter

Concord Biotech Limited key metrics

Market Cap
 223.44B
Enterprise value
 226.47B
P/E
 69.08
EV/Sales
 20.85
EV/EBITDA
 45.79
Price/Sales
 20.86
Price/Book
 14.24
PEG ratio
 0.19
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 30.2%
Oper. margin
 45.31%
Gross margin
 76%
EBIT margin
 45.31%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Concord Biotech Limited stock price history

Concord Biotech Limited stock forecast

Concord Biotech Limited financial statements

Profit Margin

Concord Biotech Limited (NSE:CONCORDBIO.NS): Profit margin
2021 6.04B 2.34B 38.89%
2024 9.98B 3.08B 30.87%
CONCORDBIO.NS income statement history

Quarterly Earnings

Concord Biotech Limited (NSE:CONCORDBIO.NS): Earnings per share (EPS)
2024-02-08 7.8 7.41
2024-05-23 9.1 9.08
CONCORDBIO.NS earnings history
0.40%
Yield TTM
Concord Biotech Limited (NSE:CONCORDBIO.NS): Payout ratio
Payout ratio 0%
Concord Biotech Limited (NSE:CONCORDBIO.NS): Dividend Yield
2020 0.82%
2022 0.72%
CONCORDBIO.NS dividends history

Debt to Assets

Concord Biotech Limited (NSE:CONCORDBIO.NS): Debt to assets
2024 17007085000 1.74B 10.23%
CONCORDBIO.NS balance sheet history

Cash Flow

Concord Biotech Limited (NSE:CONCORDBIO.NS): Cash Flow
2024 2.65B -1.54B -992.14M
CONCORDBIO.NS cash flow history

Concord Biotech Limited alternative data

Concord Biotech Limited
Employees

Concord Biotech Limited (NSE:CONCORDBIO.NS): Employee count
Jul 2024 1,377
Dec 2024 1,377

Concord Biotech Limited other data

Frequently Asked Questions (FAQ)

  • What's the price of Concord Biotech Limited stock today?

    One share of Concord Biotech Limited stock can currently be purchased for approximately $1,658.9.

  • When is Concord Biotech Limited's next earnings date?

    Unfortunately, Concord Biotech Limited's (CONCORDBIO.NS) next earnings date is currently unknown.

  • Does Concord Biotech Limited pay dividends?

    Yes, Concord Biotech Limited pays dividends and its trailing 12-month yield is 0.4% with 0% payout ratio. The last Concord Biotech Limited stock dividend of undefined was paid on 12 Sep 2025.

  • How much money does Concord Biotech Limited make?

    Concord Biotech Limited has a market capitalization of 223.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 65.23% to 9.98B US dollars. Concord Biotech Limited earned 3.08B US dollars in net income (profit) last year or $9.08 on an earnings per share basis.

  • What is Concord Biotech Limited's stock symbol?

    Concord Biotech Limited is traded on the NSE under the ticker symbol "CONCORDBIO.NS".

  • What is Concord Biotech Limited's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Concord Biotech Limited?

    Shares of Concord Biotech Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Concord Biotech Limited have?

    As Dec 2024, Concord Biotech Limited employs 1,377 workers.

  • When Concord Biotech Limited went public?

    Concord Biotech Limited is publicly traded company for more then 2 years since IPO on 18 Aug 2023.

  • What is Concord Biotech Limited's official website?

    The official website for Concord Biotech Limited is concordbiotech.com.

  • How can i contact Concord Biotech Limited?

    Concord Biotech Limited can be reached via phone at +91 79 6813 8700.

Concord Biotech Limited company profile:

Concord Biotech Limited

concordbiotech.com
Exchange:

NSE

Full time employees:

1,377

Industry:

Biotechnology

Sector:

Healthcare

Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. It provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. The company also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment; mupirocin, mupirocin calcium, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, and micafungin sodium for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.

+91 79 6813 8700
16th Floor, B-Wing
Ahmedabad, 380015

:
ISIN: INE338H01029
: